サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1356823

がん検査スクリーニング市場レポート：2030年までの動向、予測、競合分析

Cancer Testing Screening Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

がん検査スクリーニング市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年09月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

がん検査スクリーニングの動向と予測

世界のがん検査スクリーニング市場は、2024年から2030年までのCAGRが5.1％で、2030年までに推定2,142億米ドルに達すると予想されます。この市場の主な促進要因は、がん患者の有病率の上昇、正確な診断ツールと早期発見法のニーズの高まり、リキッドバイオプシーへの嗜好の高まりです。世界のがん検査スクリーニング市場の将来は、病院、診療所、診断センター、研究機関のアプリケーションにおける機会によって有望視されています。

がん検査スクリーニング市場の洞察

Lucintelの予測では、生検はがんの診断精度が高いため、予測期間中に最も高い成長が見込まれます。

病院は、確立されたインフラと医療専門家の存在が利用しやすいことから、患者が治療のためにこの施設を選好する傾向が高まっており、予測期間中に最も高い成長が見込まれます。

北米は、前立腺がんや肺がんの患者が増加し続けているため、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のがん検査スクリーニング市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のがん検査スクリーニング市場動向（2018～2023年）と予測（2024～2030年）
  • 技術別の世界のがん検査スクリーニング市場
    • イメージング
    • 生検
    • ゲノムおよび分子検査
    • 次世代シーケンス
    • RT-PCR
    • マイクロアレイ
    • バイオマーカー検査
    • その他
  • がんの種類別の世界のがん検査スクリーニング市場
    • 呼吸器系がん
    • 白血病
    • 骨髄腫とリンパ腫
    • 皮膚ガン
    • 腹部/消化器系がん
    • 泌尿器系がん
    • 内分泌系がん
    • 乳がん
    • その他
  • アプリケーション別の世界のがん検査スクリーニング市場
    • 病院
    • クリニック
    • 診断センター
    • 調査機関
    • その他
  • 最終用途別の世界のがん検査スクリーニング市場
    • 患者
    • ヘルスケア提供者
    • 診断研究所
    • 調査機関
    • 製薬会社

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のがん検査スクリーニング市場
  • 北米のがん検査スクリーニング市場
  • 欧州のがん検査スクリーニング市場
  • アジア太平洋がん検査スクリーニング市場
  • その他地域がん検査スクリーニング市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 技術別の世界のがん検査スクリーニング市場の成長機会
    • がんの種類別の世界のがん検査スクリーニング市場の成長機会
    • アプリケーション別の世界のがん検査スクリーニング市場の成長機会
    • 最終用途別の世界のがん検査スクリーニング市場の成長機会
    • 地域別の世界のがん検査スクリーニング市場の成長機会
  • 世界のがん検査スクリーニング市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のがん検査スクリーニング市場の能力拡大
    • 世界のがん検査スクリーニング市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • DiaSorin
  • Immunodiagnostic Systems
  • Epigenomics
  • Quest Diagnostics
  • F. Hoffmann-La Roche
  • VolitionRX
  • Abbott Laboratories
  • QIAGEN
  • Siemens Healthineers
目次

Cancer Testing Screening Trends and Forecast

The future of the global cancer testing screening market looks promising with opportunities in the hospital, clinic, diagnostic center, and research institute applications. The global cancer testing screening market is expected to reach an estimated $214.2 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are rising prevalence of cancer cases, growing need for accurate diagnostic tools and early detection methods, and increasing preference for liquid biopsy.

A more than 150-page report is developed to help in your business decisions.

Cancer Testing Screening by Segment

The study includes a forecast for the global cancer testing screening by technique, cancer type, application, end use, and region.

Cancer Testing Screening Market by Technique [Shipment Analysis by Value from 2018 to 2030]:

  • Imaging
  • Biopsy
  • Genomic and Molecular Tests
  • Next Generation Sequencing
  • RT-PCR
  • Microarrays
  • Biomarker Testing
  • Others

Cancer Testing Screening Market by Cancer Type [Shipment Analysis by Value from 2018 to 2030]:

  • Respiratory System Cancer
  • Leukemia
  • Myeloma and Lymphoma
  • Skin Cancer
  • Abdominal/Digestive System Cancer
  • Urinary System Cancer
  • Endocrine System Cancer
  • Breast Cancer
  • Others

Cancer Testing Screening Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Research Institutes
  • Others

Cancer Testing Screening Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Patients
  • Healthcare Providers
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical Companies

Cancer Testing Screening Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cancer Testing Screening Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cancer testing screening companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cancer testing screening companies profiled in this report include-

  • Diasorin
  • Immunodiagnostic Systems
  • Epigenomics
  • Quest Diagnostics
  • F. Hoffmann-La Roche
  • VolitionRX
  • Abbott Laboratories
  • QIAGEN
  • Siemens Healthineers

Cancer Testing Screening Market Insights

Lucintel forecasts that biopsy is expected to witness highest growth over the forecast period due to its great accuracy in the diagnosis of cancer.

Hospital is expected to witness highest growth over the forecast perioddue to rising patients preference for this facility for their treatment given to the availibility of well established infrastructure and presence of medical expertise.

North America is expected to witness highest growth over the forecast period due to constant increase in instances of prostate and lung cancer cases in the region.

Features of the Global Cancer Testing Screening Market

Market Size Estimates: Cancer testing screening market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cancer testing screening market by various segments, such as by technique, cancer type, application, end use and region in terms of($B).

Regional Analysis: Cancer testing screening market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different techniques, cancer types, applications, end uses, and region.s for the cancer testing screening market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cancer testing screening market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the cancer testing screening market size?

Answer: The global cancer testing screening market is expected to reach an estimated $214.2 billion by 2030.

Q.2. What is the growth forecast for cancer testing screening market?

Answer: The global cancer testing screening market is expected to grow with a CAGR of 5.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the cancer testing screening market?

Answer: The major drivers for this market are rising prevalence of cancer cases, growing need for accurate diagnostic tools and early detection methods, and increasing preference for liquid biopsy.

Q.4. What are the major segments for cancer testing screening market?

Answer: The future of the cancer testing screening market looks promising with opportunities in the hospital, clinic, diagnostic center, and research institute applications.

Q.5. Who are the key cancer testing screening market companies?

Answer: Some of the key cancer testing screening companies are as follows:

  • DiaSorin
  • Immunodiagnostic Systems
  • Epigenomics
  • Quest Diagnostics
  • F. Hoffmann-La Roche
  • VolitionRX
  • Abbott Laboratories
  • QIAGEN
  • Siemens Healthineers

Q.6. Which cancer testing screening market segment will be the largest in future?

Answer: Lucintel forecasts that biopsy is expected to witness highest growth over the forecast period due to its great accuracy in the diagnosis of cancer.

Q.7. In cancer testing screening market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to constant increase in instances of prostate and lung cancer cases in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cancer testing screening market by technique (imaging, biopsy, genomic and molecular tests, next generation sequencing, RT-PCR, microarrays, biomarker testing, and others), cancer type (respiratory system cancer, leukemia, myeloma and lymphoma, skin cancer, abdominal/digestive system cancer, urinary system cancer, endocrine system cancer, breast cancer, and others), application (hospitals, clinics, diagnostic centers, research institutes, and others), end use (patients, healthcare providers, diagnostic laboratories, research institutes, and pharmaceutical companies), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cancer Testing Screening Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cancer Testing Screening Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cancer Testing Screening Market by Technique
    • 3.3.1: Imaging
    • 3.3.2: Biopsy
    • 3.3.3: Genomic and Molecular Tests
    • 3.3.4: Next Generation Sequencing
    • 3.3.5: RT-PCR
    • 3.3.6: Microarrays
    • 3.3.7: Biomarker Testing
    • 3.3.8: Others
  • 3.4: Global Cancer Testing Screening Market by Cancer Type
    • 3.4.1: Respiratory System Cancer
    • 3.4.2: Leukemia
    • 3.4.3: Myeloma and Lymphoma
    • 3.4.4: Skin Cancer
    • 3.4.5: Abdominal/Digestive System Cancer
    • 3.4.6: Urinary System Cancer
    • 3.4.7: Endocrine System Cancer
    • 3.4.8: Breast Cancer
    • 3.4.9: Others
  • 3.5: Global Cancer Testing Screening Market by Application
    • 3.5.1: Hospitals
    • 3.5.2: Clinics
    • 3.5.3: Diagnostic Centers
    • 3.5.4: Research Institutes
    • 3.5.5: Others
  • 3.6: Global Cancer Testing Screening Market by End Use
    • 3.6.1: Patients
    • 3.6.2: Healthcare Providers
    • 3.6.3: Diagnostic Laboratories
    • 3.6.4: Research Institutes
    • 3.6.5: Pharmaceutical Companies

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cancer Testing Screening Market by Region
  • 4.2: North American Cancer Testing Screening Market
    • 4.2.2: North American Cancer Testing Screening Market by Application: Hospitals, Clinics, Diagnostic Centers, Research Institutes, and Others
  • 4.3: European Cancer Testing Screening Market
    • 4.3.1: European Cancer Testing Screening Market by Technique: Imaging, Biopsy, Genomic and Molecular Tests, Next Generation Sequencing, RT-PCR, Microarrays, Biomarker Testing, and Others
    • 4.3.2: European Cancer Testing Screening Market by Application: Hospitals, Clinics, Diagnostic Centers, Research Institutes, and Others
  • 4.4: APAC Cancer Testing Screening Market
    • 4.4.1: APAC Cancer Testing Screening Market by Technique: Imaging, Biopsy, Genomic and Molecular Tests, Next Generation Sequencing, RT-PCR, Microarrays, Biomarker Testing, and Others
    • 4.4.2: APAC Cancer Testing Screening Market by Application: Hospitals, Clinics, Diagnostic Centers, Research Institutes, and Others
  • 4.5: ROW Cancer Testing Screening Market
    • 4.5.1: ROW Cancer Testing Screening Market by Technique: Imaging, Biopsy, Genomic and Molecular Tests, Next Generation Sequencing, RT-PCR, Microarrays, Biomarker Testing, and Others
    • 4.5.2: ROW Cancer Testing Screening Market by Application: Hospitals, Clinics, Diagnostic Centers, Research Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cancer Testing Screening Market by Technique
    • 6.1.2: Growth Opportunities for the Global Cancer Testing Screening Market by Cancer Type
    • 6.1.3: Growth Opportunities for the Global Cancer Testing Screening Market by Application
    • 6.1.4: Growth Opportunities for the Global Cancer Testing Screening Market by End Use
    • 6.1.5: Growth Opportunities for the Global Cancer Testing Screening Market by Region
  • 6.2: Emerging Trends in the Global Cancer Testing Screening Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cancer Testing Screening Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cancer Testing Screening Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: DiaSorin
  • 7.2: Immunodiagnostic Systems
  • 7.3: Epigenomics
  • 7.4: Quest Diagnostics
  • 7.5: F. Hoffmann-La Roche
  • 7.6: VolitionRX
  • 7.7: Abbott Laboratories
  • 7.8: QIAGEN
  • 7.9: Siemens Healthineers